Whole-of-population Linked Data: Strengthening The Evidence To Drive Improvement In Health And Health Care In Australia
Funder
National Health and Medical Research Council
Funding Amount
$1,130,376.00
Summary
In partnership with the Australian Bureau of Statistics, Australian Institute of Health and Welfare and Heart Foundation, we will create a whole-of-population linked data platform to inform improvements in health and heath care. We will investigate: socioeconomic variation in disease burden, to identify opportunities to improve population health; preventive cardiovascular disease (CVD) care, to improve treatment; and end-of-life care trajectories, focusing on CVD, to inform improvements in care.
Identifying And Prioritising Points For Intervention To Reduce Cardiovascular Disease Inequalities In Australia
Funder
National Health and Medical Research Council
Funding Amount
$550,669.00
Summary
This project investigates inequalities in cardiovascular disease risk, incidence, healthcare and outcomes, focussing on socio-economic status, rurality, mental health and Aboriginality. It will work with partner organisations and use a range of data sources - including representative population data, clinical datasets, large scale linked data and qualitative data - to better understand variation in cardiovascular disease, to reduce inequalities and improve outcomes.
A Cluster RCT Of The Impact Of A Community-based Hygiene And Sanitation Programme On Infection With Intestinal Parasites Following Mass Albendazole Chemotherapy In Timor-Leste
Funder
National Health and Medical Research Council
Funding Amount
$1,178,136.00
Summary
Intestinal parasites cause anaemia, stunting, wasting and poor mental development in childhood, and are related to poverty and poor hygiene. Treatment with antiparasitic drugs cures infections in human hosts, but does not prevent rapid re-infection when people contact a parasite-contaminated environment. We will quantify the impact of a hygiene and sanitation programme that reduces environmental contamination in communities that receive mass treatment with the antiparasitic drug albendazole.